AZK teams with Daewoong over Nexium

Published: 2008-12-09 06:46:00

Updated: 2008-12-09 06:46:00

Industry watchers expect the domestic anti-ulcerant market is about to heat up, as AstraZeneca Korea (AZK) has joined hands with Daewoong Pharm to market Nexium (esomeprazole magnesium).

Esomeprazole is a proton pump inhibitor developed and marketed by AstraZeneca which is used in the treatmen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK